KRAS/ABHD17C/ALOX15B Axis Promotes Pancreatic Cancer Progression via Ferroptosis Evasion
Advanced Science · 2025-09 · 12 (35)
DOI: 10.1002/advs.202504470 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, online erschienen am 26.06.2025. Verfasst von Man Li und 12 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou…. Hauptthemen laut MEDLINE: Ferroptosis, Proto-Oncogene Proteins p21(ras), Pancreatic Neoplasms, Arachidonate 15-Lipoxygenase. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of China, National Key Research and Development Program of China, Shenzhen Medical Research Fund.
Abstract (Originalsprache)
Understanding the mechanisms underlying Kirsten rat sarcoma (KRAS) mutation‐driven development and progression of pancreatic ductal adenocarcinoma (PDAC) may facilitate the discovery of novel strategies for KRAS‐mutant PDAC (KRAS mut ‐PDAC) treatment. Here, it is reported that downregulation of arachidonate 15‐lipoxygenase (ALOX15B) significantly correlated with poor outcomes in patients with KRAS mut ‐PDAC. Mechanistically, KRAS mut /ERK1‐elicited phosphorylation of ABHD17C promotes depalmitoylation and membrane‐to–cytoplasm translocation of ALOX15B, facilitating proteasome‐dependent degradation of ALOX15B via interaction with the E3 ligase complex CUL4/DDB1/DCAF10. Notably, treatment with methyl protodioscin (MPD), a steroid saponin primarily purified from polygonatum sibiricum rhizome, restored the S‐palmitoylation and membrane location of ALOX15B via disruption of the ABHD17C/ALOX15B interaction, consequently resulting in significant inhibition of growth rate of patient‐derived KRAS mut ‐PDAC organoids in vitro and KRAS mut ‐PDAC‐formed tumor in vivo via induction of ferroptosis. Therefore, these findings unveil a prominent role of ferroptosis evasion in KRAS mut ‐PDAC progression and highlight the potential of targeting KRAS/ERK1/ABHD17C/ALOX15B axis in KRAS mut ‐PDAC treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, 510080, China.
- Department of Biochemistry, Zhongshan School of Medicine Sun Yat-sen University, Guangzhou, 510080, China.
- School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou, 510080, China.
- Department of Biochemistry and Molecular Biology, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, 510080, China.
- Guangdong Provincial Key Laboratory for Genome Stability and Disease Prevention, Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Health Science Center, Shenzhen University, Shenzhen,…
ORCID-Profile: Jun Li
Förderung
- Natural Science Foundation of China
- National Key Research and Development Program of China
- Shenzhen Medical Research Fund
- National Natural Science Foundation of China
Zitieren
APA
Li, M., Yu, X., Liu, Y., Ouyang, S., Wu, L., Chen, X., Yu, H., Chen, H., Lian, S., Li, Z., Gong, L., Song, L., & Li, J. (2025). KRAS/ABHD17C/ALOX15B Axis Promotes Pancreatic Cancer Progression via Ferroptosis Evasion. Advanced Science, 12(35). https://doi.org/10.1002/advs.202504470
Vancouver
Li M, Yu X, Liu Y, Ouyang S, Wu L, Chen X, et al. KRAS/ABHD17C/ALOX15B Axis Promotes Pancreatic Cancer Progression via Ferroptosis Evasion. Advanced Science. 2025;12(35). doi:10.1002/advs.202504470
BibTeX
@article{Li2025,
author = {Li, Man and Yu, Xuexin and Liu, Yuanji and Ouyang, Shuqin and Wu, Long and Chen, Xiaohong and Yu, Huiqi and Chen, Haoming and Lian, Senmao and Li, Ziwen and Gong, Liyun and Song, Libing and Li, Jun},
title = {KRAS/ABHD17C/ALOX15B Axis Promotes Pancreatic Cancer Progression via Ferroptosis Evasion},
journal = {Advanced Science},
year = {2025},
volume = {12},
number = {35},
doi = {10.1002/advs.202504470}
}
EUVIMED